Literature DB >> 4842666

Renal dysfunction after treatment with isophosphamide (NSC-109724).

R A DeFronzo, M Abeloff, H Braine, R L Humphrey, P J Davis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4842666

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  8 in total

Review 1.  Drug-induced acute kidney injury in children.

Authors:  Lauren N Faught; Michael J E Greff; Michael J Rieder; Gideon Koren
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

2.  Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.

Authors:  M P Goren; C B Pratt; M J Viar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Hypophosphataemic rickets after ifosfamide treatment in children.

Authors:  R Skinner; A D Pearson; L Price; K Cunningham; A W Craft
Journal:  BMJ       Date:  1989-06-10

4.  Fanconi syndrome after ifosfamide.

Authors:  M Moncrieff; A Foot
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Cytostatics--induced tubular toxicity.

Authors:  M Brandis; K von der Hardt; R B Zimmerhackl; M Mohrmann; J Leititis
Journal:  Clin Investig       Date:  1993-10

Review 6.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Nephrotoxicity after ifosfamide.

Authors:  R Skinner; A D Pearson; L Price; M G Coulthard; A W Craft
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

8.  Effects of blood purification therapy on a patient with ifosfamide-induced neurotoxicity and acute kidney injury.

Authors:  Hiroaki Nishimura; Hideki Enokida; Satoshi Nagano; Masahiro Yokouchi; Hiroshi Hayami; Setsuro Komiya; Masayuki Nakagawa
Journal:  J Artif Organs       Date:  2013-10-04       Impact factor: 1.731

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.